CancerPPD2: an updated repository of anticancer peptides and proteins

Database (Oxford). 2025 May 7;2025:baaf030. doi: 10.1093/database/baaf030.

ABSTRACT

CancerPPD2 (http://webs.iiitd.edu.in/raghava/cancerppd2/) is an updated version of CancerPPD, developed to maintain comprehensive information about anticancer peptides and proteins. It contains 6521 entries, each entry provides detailed information about an anticancer peptide/protein that include origin of the peptide, cancer cell line, type of cancer, peptide sequence, and structure. These anticancer peptides have been tested against 392 types of cancer cell lines and 28 types of cancer-associated tissues. In addition to natural anticancer peptides, CancerPPD2 contains 781 entries for chemically modified and 3018 entries for N-/C- terminus modified anticancer peptides. Few entries are also linked with 47 clinical studies and have provided the cross reference to Uniprot, DrugBank, and ThPDB2. The possible entries also linked with clinical trials. On average, CancerPPD2 contains around 85% more information than its previous version, CancerPPD. The structures of these anticancer peptides and proteins were either obtained from the Protein Data Bank (PDB) or predicted using PEPstrMOD, I-TASSER, and AlphaFold. A wide range of tools have been integrated into CancerPPD2 for data retrieval and similarity searches. Additionally, we integrated a REST API into this repository to facilitate automatic data retrieval via program. Database URL: https://webs.iiitd.edu.in/raghava/cancerppd2/api/rest.html.

PMID:40338521 | PMC:PMC12060709 | DOI:10.1093/database/baaf030